OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of plasma P-tau181 with memory decline in non-demented adults
Joseph Therriault, Andréa Lessa Benedet, Tharick A. Pascoal, et al.
Brain Communications (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients
Yanlu Huang, Yuehua Li, Fang Xie, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 12, pp. 2195-2205
Open Access | Times Cited: 15

Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer’s Disease: A Review and Meta-Analysis
Gemma Lombardi, Silvia Pancani, Riccardo Manca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12916-12916
Open Access | Times Cited: 2

Medial temporal tau predicts memory decline in cognitively unimpaired elderly
Angela T.H. Kwan, Saman Arfaie, Joseph Therriault, et al.
Brain Communications (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 11

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease
Kely Quispialaya, Joseph Therriault, Antonio Aliaga, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 12
Open Access | Times Cited: 1

APOE ε4 status and plasma p-tau181 interact to influence cognitive performance among non-demented older adults
Shanshan Wang, Shaofa Ke, Suzhi Liu, et al.
Neuroscience Letters (2023) Vol. 796, pp. 137052-137052
Open Access | Times Cited: 3

Two-year prognostic utility of plasma p217+tau across the Alzheimer’s continuum
Azadeh Feizpour, Vincent Doré, James D. Doecke, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3

Plasma p-tau181 associated with structural changes in mild cognitive impairment
Fardin Nabizadeh, Mohammad Balabandian, Mohammad Reza Rostami, et al.
Aging Clinical and Experimental Research (2022) Vol. 34, Iss. 9, pp. 2139-2147
Closed Access | Times Cited: 5

Relationship between baseline plasma p‐tau181 and longitudinal changes in cognition and structural brain measures in a cohort of cognitively unimpaired older adults
Marcos Vasconcelos Pais, Chia‐Ling Kuo, Beau M. Ances, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 2

Real‐world performance of plasma p‐tau181 in a heterogeneous memory clinic cohort
Tandis Parvizi, Raphael Wurm, Theresa König, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 8, pp. 1988-1998
Open Access

Association of plasma phosphor-tau181 with Aβ levels may vary by APOE ε4 status and sex among non-demented old adults
Yan Cai, Pan Fu, Xin Zhang
Neuroscience Letters (2023) Vol. 802, pp. 137161-137161
Open Access | Times Cited: 1

Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition
Corey J. Bolton, Marilyn Steinbach, Omair A. Khan, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024) Vol. 16, Iss. 4
Open Access

Plasma biomarkers for diagnosis of Alzheimer’s disease and prediction of cognitive decline in individuals with mild cognitive impairment
Pia Kivisäkk, Thadryan Sweeney, Becky C. Carlyle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2

Potential utility of plasma p-tau and NfL as surrogate biomarkers for preventive clinical trials
Pâmela C.L. Ferreira, João Pedro Ferrari‐Souza, Cécile Tissot, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease
Andrea Pilotto, M Parigi, Giulio Bonzi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1

Applications of Alzheimer’s disease staging to clinical trials
Joseph Therriault, Serge Gauthier, Pedro Rosa‐Neto
Aging (2023) Vol. 15, Iss. 1, pp. 4-5
Open Access

APOE ɛ4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia
Shanshan Wang, Suzhi Liu, Shaofa Ke, et al.
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 4, pp. 1509-1518
Closed Access

Association between plasma phospho-tau181 and cognitive change from age 73 to 82: Lothian Birth Cohort 1936
Tyler S. Saunders, Amanda Heslegrave, Declan King, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access

Previous Page - Page 2

Scroll to top